← Back to Search

Electrolyte Supplement

High Sodium Diet for Hypernatremia

N/A
Recruiting
Led By David G Edwards, PhD
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy individuals (age 21-45) who are either sedentary (1 or less days of exercise per week during past year) or habitually active (4 or more days of aerobic exercise per week for a minimum of 1 year)
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the morning of day 9 through the morning of day 10 for each arm.
Awards & highlights

Study Summary

This trial will study how high sodium diets affect the work of the heart by looking at changes in vascular function.

Who is the study for?
This trial is for healthy adults aged 21-45 who are either not very active (exercising at most once a week) or very active (exercising four or more days a week). People with certain health conditions, pregnant women, nursing mothers, smokers, and those outside the specified body mass index range cannot participate.Check my eligibility
What is being tested?
The study is testing how high sodium diets affect heart workload and blood vessel function. It will also explore if regular exercise offers protection against these effects. Participants will be given either a high sodium diet or a placebo to compare outcomes.See study design
What are the potential side effects?
While the trial itself does not list specific side effects, consuming high amounts of sodium can lead to increased blood pressure and may cause bloating or thirst.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 21-45 years old and either mostly inactive or very active.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the morning of day 9 through the morning of day 10 for each arm.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the morning of day 9 through the morning of day 10 for each arm. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Arterial Stiffness
Conduit artery endothelium-dependent dilation
Reflected Pulse Wave Amplitude
Secondary outcome measures
24 Hour Blood Pressure
Forward Pulse Wave Amplitude
Wave reflection timing

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: High SodiumExperimental Treatment1 Intervention
Consumption of an extra 3900 mg of dietary sodium per day.
Group II: PlaceboPlacebo Group1 Intervention
Control Condition

Find a Location

Who is running the clinical trial?

University of DelawareLead Sponsor
154 Previous Clinical Trials
25,178 Total Patients Enrolled
1 Trials studying Hypernatremia
100 Patients Enrolled for Hypernatremia
David G Edwards, PhDPrincipal InvestigatorUniversity of Delaware
3 Previous Clinical Trials
169 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment phase of this experiment currently underway?

"Evidenced by records on clinicaltrials.gov, this experimental research is presently enrolling participants. It was initially posted on January 1st 2020 and the latest update took place on Jan 16th of the same year."

Answered by AI

Does this study accept individuals aged 35 or above?

"To participate in this research project, applicants must be between 21 and 45 years of age. There is a separate clinical trial for participants under 18 as well as five more specifically designed to accommodate seniors over 65."

Answered by AI

Is there an opportunity to be included in this trial?

"This clinical trial seeks 50 individuals between the ages of 21 and 45 who have been diagnosed with hypernatremia."

Answered by AI

What is the current participation rate of this experiment?

"Affirmative. Clinicaltrials.gov verifies that this experiment, which was first released on January 1st 2020, is actively seeking participants. Approximately 50 patients are required to be enrolled from one medical centre."

Answered by AI
~3 spots leftby Jun 2024